Pharmafile Logo
Pharmafocus logo
Advanced Search
opdivo_1_1

BMS’ Opdivo becomes first immuno-oncology agent available in China

June 18, 2018
Sales and Marketing BMS, Bristol-Myers Squibb, Cancer, China, NSCLC, lung cancer, oncology, opdivo, pharma

Bristol-Myers Squibb’s flagship immunotherapy Opdivo (nivolumab) has broken ground to become the first and only PD-1 inhibitor to be made …

News
theresa_may_-_arno_mikkor

£20bn promised to NHS but questions over where money will come from

June 18, 2018
Medical Communications, Sales and Marketing NHS, UK government, biotech, drugs, pharma, pharmaceutical

Theresa May finally attempted to tackle the elephant in the room for the UK government, well, the one other than …

News
top_ten

Top Ten most popular articles on Pharmafile.com this week

June 15, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

Another busy in week in pharma has seen a number of companies release promising data on their drugs, Roche’s study …

News
allergan

Allergan appoints ex-Abbott exec in “Board refreshment” move

June 15, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbott, Allergan, appointment, pharma

Allergan has announced another move in its “refreshment” of its executive Board of Directors with the appointment of Thomas C …

News

New Jersey attempts to lure Teva HQ with tax incentives

June 15, 2018
Medical Communications Teva, biotech, drugs, pharma, pharmaceutical

Teva has been doing some major global restructuring since Kare Schultz came to the helm of the embattled, Israeli drugmaker. …

News
rocherooflr

NICE turns down Roche’s Perjeta for post-surgery HER2-positive breast cancer

June 15, 2018
Medical Communications, Sales and Marketing Cancer, NICE, Perjeta, Roche, breast cancer, pharma

Roche’s ongoing dispute with UK health service watchdog NICE over the availability of its monoclonal antibody Perjeta (pertuzumab) on the …

News
wheelchair-1595802_960_720

Gene therapy offers hope for those with paralysis

June 15, 2018
Medical Communications, Research and Development biotech, drugs, pharma, pharmaceutical

Researchers at King’s College London (KCL) have made significant progress to being able to offer a treatment to those with …

News

Living with childhood dementia

June 14, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing childhood dementia, dementia, feature, patient experience, pharma

Claire Young explores her family’s journey through the diagnosis of her son George, who lives with Batten disease, a form …

Feature
roche

Roche’s Ocrevus extends time-to-wheelchair by 7 years in progressive MS patients

June 14, 2018
Research and Development Ocrevus, Roche, multiple sclerosis, pharma

Roche has lifted the curtain on more promising data at Phase 3 for its humanised anti-CD20 monoclonal antibody Ocrevus (ocrelizumab), …

News

Danger of Sanofi’s dengue vaccine confirmed in new study

June 14, 2018
Medical Communications, Research and Development Sanofi, biotech, dengue, dengvaxia, drugs, pharma, pharmaceutical

A study that thoroughly analyses the impact of Sanofi’s dengue vaccine has confirmed what was feared – children without prior …

News
mylan_building

FDA knocks back Mylan’s Advair generic for second time

June 14, 2018
Sales and Marketing Advair, FDA, GSK, Mylan, pharma

The FDA has rejected Mylan’s generic version of GlaxoSmithKline’s Advair for the second time following its knockback last year, citing …

News
nhs_parliament_2_4

UK immigration rules to be waived to bring in more doctors

June 14, 2018
Medical Communications NHS, biotech, drugs, pharma, pharmaceutical

The NHS’ recruitment crisis has been on-going for a number of years, with an ageing population and a higher workload …

News
line_of_people

Report highlights that half of women in science face harassment

June 14, 2018
Medical Communications biotech, drugs, pharma, pharmaceutical

Arriving at a particularly low point for the reputation of the biotech, after STAT revealed that a party at BIO …

News
apps_mobile

UK demand for mental health apps soars 566% since 2014

June 13, 2018
Medical Communications, Research and Development UK, apps, mental health, pharma

A new report from communications and research agencies GK Strategy and onefourzero has revealed the massive extent to which consumer …

News
vaccination-2722937_960_720

Vaccination rates in parts of US fall to dangerous levels

June 13, 2018
Research and Development anti-vax, biotech, drugs, pharma, pharmaceutical, vaccination

The anti-vaxxer movement is the scourge of meticulously researched science and yet, in certain states in the US, it seems …

News
celgene_1_02

Celgene showcases strong Otezla data in psoriatic arthritis

June 13, 2018
Research and Development Celgene, EULAR, otezla, pharma

Celgene has seized the opportunity at the Annual European Congress of Rheumatology in Amsterdam to reveal positive new data for …

News

J&J continues to shed assets, with $2.1bn diabetes unit sale

June 13, 2018
Research and Development, Sales and Marketing Johnson & Johnson, biotech, drugs, pharma, pharmaceutical

Just last week, Johnson & Johnson announced that it had received an offer from Fortive for its medical sterilisation unit, …

News
old_hands_stick

Investors stump up cash for anti-ageing start-up

June 12, 2018
Research and Development, Sales and Marketing Juvenescence, biotech, drugs, pharma, pharmaceutical

Defeating the ageing process is a pie-in-the-sky idea that has resulted, so far, in a rich vein of parody rather …

News
brexit

Brexit negotiations: Is the public’s health a priority?

June 12, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, brexit, drugs, pharma, pharmaceutical

The Brexit decision has created a huge amount of question marks for many industries and each is vying with each …

Feature
dna-1903319_960_720

Research casts doubts over CRISPR safety

June 12, 2018
Manufacturing and Production, Research and Development biotech, crispr, drugs, pharma, pharmaceutical

Research emerging from two studies, published in same issue of Nature, has raised significant questions over just how safe CRISPR …

News
The Gateway to Local Adoption Series

Latest content

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026